By Josh White
Date: Friday 28 Aug 2020
LONDON (ShareCast) - (Sharecast News) - Health technology company Induction Healthcare announced on Friday that its 'Induction Switch' platform has been awarded supplier status on the 'Clinical Communications Procurement Framework', operated by the National Commercial and Procurement Hub on behalf of NHSX.
The AIM-traded firm described NHSX as a joint unit working to "drive forward" the digital transformation of care in the UK.
It said the procurement framework was established to support NHS organisations by providing clinicians with access to a range of dedicated clinical-facing communication and task management tools, to accelerate the adoption of proven technologies.
The framework has been granted £3m of government funding to aid the move towards more modern forms of communication, and to phase out pagers by the end of 2021.
Induction said the framework was scheduled to run from 3 August 2020 to 3 August 2022, with a possible extension of a further 12 months.
Induction Healthcare said its products are routinely used by "hundreds of thousands" of NHS staff and patients, and had been "heavily" relied on during the Covid-19 pandemic to deliver care under challenging conditions.
The inclusion of 'Induction Switch' on the framework provided what the board described as "strong validation" of the company's standards of clinical safety, data security and information governance, further supported by its ISO 27001, ISO 9001, Cyber Essentials, and NHS DSPT certifications.
"We are proud to have been selected for the NHSX Clinical Communications Procurement Framework and are confident it will enable easier access to clinical facing communication and task management tools used by hundreds of thousands of NHS staff across the UK on a daily basis," said joint chief executive officer Hugo Stephenson.
"This success highlights, once again, the strength of Induction's technology and its commitment to improve the delivery of care."
At 1051 BST, shares in Induction Healthcare were down 2.8% at 85.05p.
Email this article to a friend
or share it with one of these popular networks:
Currency | UK Pounds |
Share Price | 9.00p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 27.40p |
52 Week Low | 7.00p |
Volume | 0 |
Shares Issued | 92.38m |
Market Cap | £8.31m |
Beta | 0.41 |
RiskGrade | 132 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
CEO | Paul Tambeau |
CFO | John McIntosh |
You are here: research